These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7155309)

  • 1. Serotonin receptor blockade potentiates behavioural effects of beta-phenylethylamine.
    Goudie AJ; Buckland C
    Neuropharmacology; 1982 Dec; 21(12):1267-72. PubMed ID: 7155309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural effects of acute and chronic beta-phenylethylamine administration in the rat: evidence for the involvement of 5-hydroxytryptamine.
    Dourish CT
    Neuropharmacology; 1981 Nov; 20(11):1067-72. PubMed ID: 7322283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
    Dourish CT
    Br J Pharmacol; 1982 Sep; 77(1):129-39. PubMed ID: 6982090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deuterium substitution enhances the effects of beta-phenylethylamine on spontaneous motor activity in the rat.
    Dourish CT; Greenshaw AJ; Boulton AA
    Pharmacol Biochem Behav; 1983 Sep; 19(3):471-5. PubMed ID: 6634898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phenylethylamine on rat locomotor behavior and avoidance learning.
    Tannhauser SL; Elsner J; Tannhauser M; Barros HM; Tannhauser MA
    Braz J Med Biol Res; 1989; 22(2):213-24. PubMed ID: 2790290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of total horizontal activity and ambulation in rats treated with combinations of beta-phenylethylamine and naloxone.
    Dourish CT; Cooper SJ
    Neuropharmacology; 1984 Sep; 23(9):1059-64. PubMed ID: 6096756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of analgesia induced by noncatecholic phenylethylamine derivatives: possible involvement of endogenous opioid peptides and serotonin in phenylethylamine analog-induced analgesia.
    Natsuoka Y; Sakuma M; Uruno T; Kubota K
    Jpn J Pharmacol; 1984 Mar; 34(3):277-87. PubMed ID: 6233440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behaviourally specific interactions between naloxone and beta-phenylethylamine in an operant drug discrimination procedure in rats.
    Goudie AJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):199-202. PubMed ID: 3562493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavior maintained under fixed-interval and second-order schedules by intravenous injections of endogenous noncatecholic phenylethylamines in dogs.
    Shannon HE; Thompson WA
    J Pharmacol Exp Ther; 1984 Mar; 228(3):691-5. PubMed ID: 6707918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly synthesized noradrenaline mediates the alpha 2-adrenoceptor inhibition of [3H]5-hydroxytryptamine release induced by beta-phenylethylamine in rat hippocampal slices.
    Benkirane S; Arbilla S; Langer SZ
    Eur J Pharmacol; 1986 Nov; 131(2-3):189-98. PubMed ID: 3028829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance development to a disruptive effect of beta-phenylethylamine (PEA) on a learned behavior in rats.
    Stoff DM; Moja EA; Jeffery DR; Gillin JC; Wyatt RJ
    Psychopharmacology (Berl); 1979 Nov; 66(2):127-31. PubMed ID: 119255
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 13. The behavioural effects of phenelzine and phenylethylamine may be due to amine release.
    Dyck LE
    Brain Res Bull; 1984 Jan; 12(1):23-8. PubMed ID: 6713212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An observational analysis of the behavioural effects of beta-phenylethylamine in isolated and grouped mice.
    Dourish CT
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(2):143-58. PubMed ID: 7202236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensification of amphetamine-induced excitation by methysergide, a serotonergic receptor blocker.
    Blum K; Wallace JE; Meyer E; Schwertner HA
    Experientia; 1977 Feb; 33(2):213-5. PubMed ID: 844561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin agonist actions of p-chlorophenylalanine.
    Sloviter RS; Drust EG; Connor JD
    Neuropharmacology; 1978 Dec; 17(12):1029-33. PubMed ID: 154622
    [No Abstract]   [Full Text] [Related]  

  • 17. [beta-Phenylethylamine and amphetamine: similar aspects in their behavioropharmacological and neurochemical characteristics].
    Hirano M; Uchimura H; Shiraishi A; Kuroki T; Matsumoto T; Tsutsumi T
    Yakubutsu Seishin Kodo; 1989 Dec; 9(4):335-48. PubMed ID: 2698018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new animal model for schizophrenia: cholinergic and serotonergic modulation.
    Borison RL; Havdala HS; Diamond BI
    Commun Psychopharmacol; 1978; 2(3):209-14. PubMed ID: 308873
    [No Abstract]   [Full Text] [Related]  

  • 19. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enigma of conditioned taste aversion learning: stimulus properties of 2-phenylethylamine derivatives.
    Greenshaw AJ; Turrkish S; Davis BA
    Physiol Res; 2002; 51 Suppl 1():S13-20. PubMed ID: 12479782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.